Carmustine Kit
Product Images NDC 75907-327

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carmustine (NDC 75907-327). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

Packaging label for Carmustine for Injection, USP 100 mg per vial, single-dose vial kit by Dr. Reddy's Laboratories Inc. The carton contains 1 vial of carmustine for injection and 1 vial of sterile diluent, 3 mL. Instructions emphasize intravenous infusion after reconstitution and refrigerated storage. The label includes handling precautions indicating cytotoxicity and disposal of unused portions.*

FDA Label Image

Diluent (Diluent)

Label for Dehydrated Alcohol Injection, USP, 3 mL sterile diluent for carmustine for injection. It is produced by Dr. Reddy's Laboratories Inc., Princeton, NJ, made in India. The label includes storage instructions to refrigerate at 2°C to 8°C (36°F to 46°F) and features a barcode and a designated varnished area for lot and expiration date.*

FDA Label Image

Label (Label)

Label for Carmustine for Injection, USP, 100 mg per vial, single-dose vial kit for intravenous infusion after reconstitution. The label includes storage instructions to refrigerate immediately and discard any unused portion. It is distributed by Dr. Reddy's Laboratories Inc. The label also bears a barcode, NDC 75907-326-11, and cautions about wearing gloves and cytotoxic agent handling.*

FDA Label Image

Ifs (Ifs)

An instructional image set demonstrates the preparation steps of carmustine for injection, USP 100 mg vial in a KIT form. The images show handling vials in a COMBI KIT guard: removing flip seals, aseptically withdrawing sterile diluent with a syringe, injecting it into the vial containing carmustine, shaking to dissolve, and adding sterile water for injection.*

FDA Label Image

Ifu2 (Ifu2)

An instructional image showing two step-by-step photos for preparing carmustine intravenous kit by Dr. Reddy's Laboratories Inc. Step 7 depicts a hand holding and gently shaking the combined vial kit. Step 8 shows aseptic removal and preparation for infusion with a syringe, illustrating proper handling for dilution with appropriate injections.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of carmustine, showing its molecular composition with chlorine atoms, carbamoyl groups, and nitroso functional group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.